Medication safety in patients treated with new oral antitumor agents: a prospective, randomized investigation on the impact of intensified clinical pharmaceutical/ clinical pharmacological care on patient safety and well-being (AMBORA-Study - supported by the German Cancer Aid (70112447))

Beitrag bei einer Tagung


Details zur Publikation

Autorinnen und Autoren: Duerr P, Schlichtig K, Dörje F, Fromm M
Verlag: SPRINGER
Verlagsort: NEW YORK
Jahr der Veröffentlichung: 2019
Tagungsband: NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
ISSN: 0028-1298
eISSN: 1432-1912


FAU-Autorinnen und Autoren / FAU-Herausgeberinnen und Herausgeber

Dörje, Frank Prof. Dr.
Lehrstuhl für Pharmazeutische Technologie
Fromm, Martin Prof. Dr.
Lehrstuhl für Klinische Pharmakologie und Klinische Toxikologie
Schlichtig, Katja
Lehrstuhl für Klinische Pharmakologie und Klinische Toxikologie


Zitierweisen

APA:
Duerr, P., Schlichtig, K., Dörje, F., & Fromm, M. (2019). Medication safety in patients treated with new oral antitumor agents: a prospective, randomized investigation on the impact of intensified clinical pharmaceutical/ clinical pharmacological care on patient safety and well-being (AMBORA-Study - supported by the German Cancer Aid (70112447)). In NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Stuttgart, GERMANY: NEW YORK: SPRINGER.

MLA:
Duerr, P., et al. "Medication safety in patients treated with new oral antitumor agents: a prospective, randomized investigation on the impact of intensified clinical pharmaceutical/ clinical pharmacological care on patient safety and well-being (AMBORA-Study - supported by the German Cancer Aid (70112447))." Proceedings of the 21st Annual Meeting of the German-Society-for-Experimental-and-Clinical-Pharmacology-and-Toxicology (DGPT) / 21st Annual Meeting of the Association-of-the-Clinical-Pharmacology-Germany (VKliPha), Stuttgart, GERMANY NEW YORK: SPRINGER, 2019.

BibTeX: 

Zuletzt aktualisiert 2019-10-07 um 10:47